Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19010153 | ULTRA-MINIATURIZED WIRELESS-CONTROLLED PATCH TYPE DRUG PUMP AND ITS PREPARATION METHOD | January 2025 | September 2025 | Allow | 9 | 0 | 1 | No | No |
| 18819570 | Medicament Delivery Device | August 2024 | August 2025 | Allow | 11 | 1 | 1 | No | No |
| 18507889 | MACROPOROUS SOLID HARD MICRONEEDLES WITH EMBEDDED PARTICULATE DRUGS | November 2023 | December 2025 | Allow | 25 | 5 | 0 | Yes | No |
| 18475015 | SYSTEMS AND METHODS FOR TREATING SKIN | September 2023 | February 2026 | Allow | 28 | 5 | 0 | No | No |
| 18159611 | Method for Operating a Benefit Agent Delivery System Comprising Microcells Having an Electrically Eroding Sealing Layer | January 2023 | February 2024 | Allow | 12 | 1 | 0 | No | No |
| 17800893 | PLASMA GENERATION UNIT AND PLASMA TREATMENT APPARATUS | August 2022 | February 2026 | Allow | 42 | 1 | 0 | Yes | No |
| 17876626 | CANNULA AND OBTURATOR SYSTEM FOR MINIMALLY INVASIVE SURGERY | July 2022 | March 2026 | Abandon | 43 | 0 | 1 | No | No |
| 17642822 | APPARATUS AND METHOD FOR PHACOEMULSIFICATION | March 2022 | December 2025 | Abandon | 45 | 1 | 0 | No | No |
| 17635601 | Cannula Comprising an Expandable Arrangement, Corresponding Cannula System and Method for Inserting at Least One Cannula into a Subject | February 2022 | December 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17645394 | LOW DEAD SPACE NEEDLE HUB | December 2021 | June 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17539471 | INTRAVASCULAR ULTRAVIOLET CATHETER AND METHODS FOR MAKING AND USING THE SAME | December 2021 | March 2026 | Abandon | 52 | 2 | 1 | No | No |
| 17533782 | PERIPHERAL ARTERY BALLOON, A HYPO-TUBE FOR PREPARING A PERIPHERAL ARTERY BALLOON AND METHODS OF USE THEREOF | November 2021 | October 2025 | Abandon | 47 | 3 | 1 | No | No |
| 17610267 | PUNCTURE-ASSISTANCE TOOL, PUNCTURE DEVICE, AND PUNCTURE METHOD | November 2021 | August 2025 | Abandon | 45 | 1 | 0 | No | No |
| 17513443 | SYSTEMS, APPARATUS, AND METHODS FOR ADMINISTERING A SUBSTANCE | October 2021 | August 2025 | Abandon | 46 | 2 | 0 | Yes | No |
| 17448763 | SYRINGE CAP, SYRINGE ASSEMBLY, AND PRE-FILLED SYRINGE | September 2021 | February 2025 | Allow | 41 | 1 | 0 | No | No |
| 17447786 | CATHETER NEEDLE ASSEMBLY WITH ENCLOSABLE NEEDLE | September 2021 | October 2025 | Abandon | 49 | 1 | 0 | No | No |
| 17446306 | DRUG DELIVERY DEVICE USING ULTRASONIC WAVE | August 2021 | August 2023 | Abandon | 24 | 1 | 0 | No | No |
| 17430911 | SAFE INSULIN NEEDLE | August 2021 | June 2025 | Allow | 46 | 1 | 0 | No | No |
| 17380791 | Pressure Waves for Vaccines, Genetic Modification and Medical Treatments | July 2021 | February 2025 | Abandon | 43 | 3 | 0 | No | No |
| 17369863 | ABSORPTION ENHANCING WEARABLE DEVICE | July 2021 | April 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17369665 | CRADLE FOR AN INFUSION PUMP UNIT | July 2021 | December 2025 | Allow | 54 | 2 | 0 | Yes | No |
| 17365316 | PREFILLED SYRINGE, SYRINGE ASSEMBLY, METHOD FOR MANUFACTURING PREFILLED SYRINGE, AND METHOD FOR INCREASING SURFACE AREA | July 2021 | July 2023 | Allow | 25 | 1 | 0 | Yes | No |
| 17364229 | ASSEMBLY FOR TRACHEAL INSTILLATION OF FLUID MEDICAMENTS IN INFANTS SUPPORTED BY NON-INVASIVE VENTILATION | June 2021 | May 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17360694 | Rapidly Insertable Central Catheters Including Assemblies and Methods Thereof | June 2021 | December 2024 | Allow | 41 | 2 | 1 | No | No |
| 17358504 | Rapidly Insertable Central Catheters Including Catheter Assemblies and Methods Thereof | June 2021 | July 2024 | Allow | 37 | 2 | 1 | Yes | No |
| 17336263 | DYNAMIC MIXING AND DELIVERY SYSTEM FOR MIXING A THERAPEUTIC AGENT IN AN INJECTOR OR AUTOINJECTOR | June 2021 | June 2024 | Allow | 37 | 2 | 0 | No | No |
| 17295930 | SINGLE-USE CASSETTE ASSEMBLY | May 2021 | November 2025 | Allow | 53 | 3 | 0 | Yes | No |
| 17295275 | METHODS AND DEVICES FOR TREATING A DISEASE WITH BIOTHERAPEUTICS | May 2021 | November 2025 | Abandon | 54 | 3 | 0 | No | No |
| 17315873 | Hard-Packaged Safety Needle Device | May 2021 | June 2024 | Allow | 38 | 2 | 1 | No | No |
| 17316403 | INFILTRATION CANNULA WITH DUAL ANGLE CONFIGURATION | May 2021 | December 2023 | Allow | 31 | 2 | 0 | Yes | No |
| 17241616 | SYSTEM FOR GRAVITY INCLUSION OF POWDER INTO A MEDICAL DELIVERY FLOW STREAM | April 2021 | February 2025 | Allow | 46 | 4 | 1 | No | No |
| 17237909 | Rapidly Insertable Central Catheters Including Catheter Assemblies and Methods Thereof | April 2021 | October 2023 | Allow | 30 | 1 | 1 | Yes | No |
| 17232594 | PERCUTANEOUS PULMONARY ARTERY DRAINAGE DEVICE | April 2021 | September 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17232265 | BABY/INFANT/TODDLER NASAL ASPIRATOR | April 2021 | September 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17231075 | DEVICES AND METHODS FOR PROVIDING A BOLUS DOSE IN A MICROFLUIDIC CIRCUIT OF A PUMP | April 2021 | December 2024 | Allow | 44 | 1 | 1 | No | No |
| 17228867 | THERMOFORMED MEDICAL SYRINGE | April 2021 | March 2024 | Allow | 35 | 2 | 1 | Yes | No |
| 17276774 | MICRONEEDLE HAVING LAYERED STRUCTURE | March 2021 | September 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17186989 | ADAPTIVE PRESSURE CONTROL FILTER FOR A FLUID MANAGEMENT SYSTEM | February 2021 | October 2025 | Allow | 55 | 6 | 1 | No | No |
| 17180611 | BRAIN DRUG DELIVERY SYSTEM AND METHOD | February 2021 | December 2023 | Abandon | 34 | 1 | 1 | No | No |
| 17269016 | Cradle Unit for Delivery Device | February 2021 | August 2025 | Abandon | 53 | 2 | 1 | No | No |
| 17248996 | Gas Management for Jetting Cartridge | February 2021 | September 2023 | Allow | 31 | 0 | 0 | No | No |
| 17269131 | DEVICE COMPRISING MICRONEEDLES FOR COSMETIC FILLERS DELIVERY | February 2021 | March 2026 | Abandon | 60 | 4 | 1 | No | No |
| 17171478 | MEDICAL DEVICE AND MEDICAL DEVICE SET | February 2021 | September 2024 | Abandon | 44 | 2 | 1 | No | No |
| 17167526 | SYSTEM, DEVICE AND METHOD COMBINING BIOABSORBABLE FOAM WITH VACUUM TECHNOLOGY FOR NEOPLASTIC CYSTS | February 2021 | January 2025 | Allow | 47 | 4 | 1 | Yes | No |
| 17165764 | CAPACITOR DETECTION FOR IV PUMP TUBE CALIBRATION | February 2021 | March 2026 | Abandon | 60 | 4 | 0 | No | No |
| 17127642 | DUAL CARTRIDGE CONTAINER APPLICATOR WITH NEEDLE PENETRATION CONNECTION TO TIP | December 2020 | September 2024 | Allow | 45 | 4 | 0 | No | No |
| 17123899 | MODULAR POWER AND CONNECTIVITY SYSTEM FOR INFUSION DEVICES | December 2020 | February 2026 | Allow | 60 | 7 | 1 | No | Yes |
| 17114137 | MACHINE LEARNING IN AN ARTIFICIAL PANCREAS | December 2020 | October 2025 | Allow | 58 | 6 | 0 | Yes | No |
| 17114213 | MACHINE LEARNING IN AN ARTIFICIAL PANCREAS | December 2020 | August 2025 | Allow | 56 | 5 | 0 | Yes | Yes |
| 16952433 | BENEFIT AGENT DELIVERY SYSTEM COMPRISING MICROCELLS HAVING AN ELECTRICALLY ERODING SEALING LAYER | November 2020 | January 2024 | Allow | 38 | 2 | 1 | No | No |
| 16951451 | STERILE CONNECTOR AND CANNULA ASSEMBLY | November 2020 | January 2025 | Allow | 50 | 3 | 0 | No | No |
| 17087583 | Fixture For Filling Hypodermic Syringes | November 2020 | September 2023 | Allow | 34 | 2 | 0 | No | No |
| 17051579 | IMPLANTABLE ACCESS DEVICE FOR ACCESSING THE VASCULAR SYSTEM OF A HUMAN OR ANIMAL BODY, PARTICULARLY SUBCUTANEOUSLY IMPLANTABLE ACCESS PORT | October 2020 | February 2025 | Allow | 52 | 4 | 0 | No | No |
| 17075423 | SYSTEMS AND METHODS FOR AUTOMATED INSULIN DELIVERY RESPONSE TO INACCURATE OR MISSED GLUCOSE VALUES | October 2020 | October 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 17048007 | SHOCK ABSORBER FOR INJECTION DEVICES | October 2020 | October 2024 | Allow | 48 | 4 | 1 | Yes | No |
| 17046403 | Tool for Removing a Cap From a Medical Injection Device | October 2020 | September 2024 | Allow | 47 | 3 | 1 | No | No |
| 17045676 | ELECTROHYDRAULIC MICROJET DRUG DELIVERY DEVICE | October 2020 | September 2023 | Allow | 36 | 3 | 0 | No | No |
| 17035989 | WEARABLE AUTO-INJECTOR DEVICES AND METHODS | September 2020 | September 2024 | Abandon | 48 | 3 | 0 | No | No |
| 17036217 | DRUG DELIVERY DEVICE | September 2020 | September 2025 | Allow | 59 | 7 | 0 | No | No |
| 17034821 | CANNULA FIXATION DEVICE | September 2020 | March 2025 | Allow | 53 | 4 | 0 | No | No |
| 17030336 | CARTRIDGE HOLDER AND MEDICINE INJECTION DEVICE COMPRSING THE SAME | September 2020 | August 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16968774 | IMPLANT CAPABLE OF RELEASING DRUG, AND MANUFACTURING AND USAGE METHODS THEREFOR | August 2020 | August 2025 | Abandon | 60 | 3 | 1 | No | No |
| 16964419 | TUBE ASSEMBLY AND DISSOLVABLE TIP | July 2020 | May 2024 | Abandon | 46 | 1 | 0 | No | No |
| 16918471 | MEDICAL TUBE | July 2020 | July 2024 | Abandon | 49 | 2 | 0 | Yes | No |
| 16772565 | Therapeutic Agent Delivery Devices Having Integrated Pain Mitigation, and Methods for Using the Same | June 2020 | May 2024 | Abandon | 47 | 2 | 1 | No | No |
| 16870574 | LARYNGEAL MASK AIRWAY FOR GASTROSCOPY | May 2020 | July 2024 | Allow | 50 | 2 | 0 | No | No |
| 16741998 | CATHETER FLUSH DEVICE, SYSTEM, AND METHODS | January 2020 | June 2025 | Allow | 60 | 4 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DIOP, FATIMATA SAHRA.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner DIOP, FATIMATA SAHRA works in Art Unit 3783 and has examined 58 patent applications in our dataset. With an allowance rate of 56.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner DIOP, FATIMATA SAHRA's allowance rate of 56.9% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by DIOP, FATIMATA SAHRA receive 2.53 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by DIOP, FATIMATA SAHRA is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +40.2% benefit to allowance rate for applications examined by DIOP, FATIMATA SAHRA. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 21.1% of applications are subsequently allowed. This success rate is in the 24% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 30.2% of cases where such amendments are filed. This entry rate is in the 44% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.1% of allowed cases (in the 83% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.